article thumbnail

Breaking Down Barriers: Data Quality as a Driver for Pharma Transformation

Reltio

In this blog post, we explore the significance of data quality in the pharmaceutical industry and explain how a modern MDM platform serves to address these challenges. Digital challenges are everywhere for pharmaceutical companies There are several reasons why pharmaceutical companies need to rapidly transform and get more from their data.

MDM 52
article thumbnail

How to protect healthcare and life-sciences data from a cyber attack pandemic

Thales Cloud Protection & Licensing

For example, the consulting company Mckinsey found that the usage of telehealth has grown 38 times if compared to the usage before the pandemic. This convergence has created major privacy and data protection vulnerabilities and place healthcare and life sciences organizations at risk. The digitalization of the healthcare.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Privacy and Cybersecurity Top 10 for 2018

Data Matters

This past year was marked by ever more significant data breaches, growing cybersecurity regulatory requirements at the state and federal levels and continued challenges in harmonizing international privacy and cybersecurity regulations. As we begin this New Year, here is list of the top 10 privacy and cybersecurity issues for 2018: EU GDPR.

article thumbnail

MY TAKE: Why ‘basic research’ is so vital to bringing digital transformation to full fruition

The Last Watchdog

Ongoing basic research in advanced cryptography concepts is pivotal to putting the brakes on widening cyber risks and ultimately arriving at a level of privacy and security that makes sense. Biomedical engineer Dr. Joe Alexander, the former medical director at pharmaceutical giant Pfizer, grabbed a distinguished scientist post, as well.

article thumbnail

NHS’ Plans to Share Patient Records with Third Parties

Data Matters

Who will the data be shared with: According to the Notice, data collected may be shared with a number of third parties including, for example, “research organisations, including universities, charities, clinical research organisations that run clinical trials and pharmaceutical companies”.

article thumbnail

Delivering responsible AI in the healthcare and life sciences industry

IBM Big Data Hub

There are many elements required to earn people’s trust, including making sure that your AI model is accurate, auditable, explainable, fair and protective of people’s data privacy. Created by a respected Tennessee pharmaceutical firm, Elixir Sulfanilamide was a liquid medication touted to dramatically cure strep throat.

article thumbnail

California Consumer Privacy Act: The Challenge Ahead – Four Key Considerations for Health and Life Sciences Companies

HL Chronicle of Data Protection

This is the sixth installment in Hogan Lovells’ series on the California Consumer Privacy Act. The California Consumer Privacy Act of 2018 (CCPA) adds another set of privacy requirements for health and life sciences companies. Some considerations in making that assessment: Is the company a provider of health care?

Privacy 45